Showing results (2021-2030 of 2,225) with videos related to

Sort By:
Pageof 223
Research Square|June 4, 2026
A Novel Patient-Derived Xenograft Model of Inflammatory Breast CancerPrincess Ekpo, Monica Khattak, Tiffany Cheung, et al.
Annals of Neurology|August 2, 2003
Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutationStephen Hague, Ekaterina Rogaeva, Dena Hernandez, et al.
Clinical Nuclear Medicine|April 22, 2021
Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or NegativeKatherine Zukotynski, Sandra E Black, Phillip H Kuo, et al.
Neurology|February 5, 2024
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical TrialR Matthew Hutchison, Kyle Fraser, Minhua Yang, et al.
Molecular Neurobiology|March 14, 2026
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmaciesMaximilian Meyer, C Felix Mosandl, Adrian Guessoum, et al.
Alzheimer'S Research & Therapy|December 9, 2014
Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomographyMichael R Misch, Sara Mitchell, Philip L Francis, et al.
Frontiers in Aging Neuroscience|February 2, 2018
[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear PalsyMatthias Brendel, Sonja Schönecker, Günter Höglinger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 18, 2018
Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depressionSandra K Bopp, Urs Heilbronner, Peter Schlattmann, et al.
Brain : a Journal of Neurology|October 23, 2008
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's diseaseValerie Voon, Paul Krack, Anthony E Lang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2017
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trialsAlberto J Espay, Michael A Schwarzschild, Caroline M Tanner, et al.
Pageof 223